IPAMORELIN 10mg

Sold out
IPAMORELIN 10mg
A$85.00

Documentation: Batch-specific Certificates of Analysis (COAs) are included within the product image gallery for reference.

 

FOR RESEARCH USE ONLY

Intended Use: This product is supplied strictly for laboratory research use only. Not for human or veterinary use.



Ipamorelin, 10 mg is a synthetic pentapeptide classified as a growth hormone secretagogue, designed to selectively stimulate endogenous growth hormone release via activation of the growth hormone secretagogue receptor (GHS-R, also referred to as the ghrelin receptor). Ipamorelin has been investigated in experimental settings for its interaction with neuroendocrine pathways involved in growth hormone regulation.

 

Ipamorelin has been studied primarily in non-clinical, preclinical, and limited early-phase clinical research contexts. At present, ipamorelin is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease or medical condition.


Technical Specifications - IPAMORELIN 10mg

  • Name: Ipamorelin (synthetic pentapeptide; growth hormone secretagogue)
  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
    (Also commonly referred to as “Ipamorelin acetate” in research-grade listings.)
  • Molecular Weight: Approx. 711.85 Da
  • Molecular Formula: C₃₈H₄₉N₉O₅
  • CAS Number: 170851-70-4
  • Physical Form: Lyophilized (freeze-dried) white to off-white powder (research grade)
  • Purity: Research-grade suppliers typically list ≥ 98–99% purity (HPLC verified)
  • Solubility:
    • Soluble in sterile water for in-vitro applications
    • Can be dissolved in dilute acetic acid (e.g., 0.1%) before dilution if needed
    • Soluble in DMSO, ethanol, and buffered aqueous solutions depending on application
  • Storage / Handling:
    • Before reconstitution: Store at –20 °C or colder, in a sealed container protected from light and moisture
    • After reconstitution: Refrigerate at 2–8 °C; avoid repeated freeze–thaw cycles
    • Allow vial to reach room temperature before opening to prevent moisture condensation
  • Intended Application:
    Labeled Research Use Only (RUO) — for in-vitro or laboratory research.
    Not approved for human or veterinary therapeutic use.
  • General Notes:
    Ipamorelin is a selective agonist of the ghrelin (GHS-R1a) receptor and is studied for its ability to stimulate growth hormone release in controlled research environments. Long-term safety, toxicity, and clinical effectiveness have not been established in humans.

 


PRODUCT DISCLAIMER

 

This product is supplied for laboratory research use only. It has not been approved by any national regulatory authority (including the FDA, EMA, or Australian TGA) for human therapeutic, diagnostic, or veterinary use. The purchaser assumes all responsibility for the handling, storage, and disposal of this material in accordance with applicable institutional, local, and national regulations.

 

The manufacturer/distributor makes no claims regarding the safety, efficacy, or suitability of this material for any medical application or human administration. This product should not be ingested, injected, or otherwise administered to humans or animals except within the context of an approved clinical trial using appropriate GMP-grade material and regulatory approvals.

 

This product should be handled only by qualified personnel trained in laboratory safety and in the handling of research reagents. Keep out of reach of children. Improper use may cause harm. The product is supplied “as is”, and no warranty, express or implied, is made regarding fitness for a particular purpose. Individual results may vary. The purchaser should review all available safety data and consult institutional safety officers prior to use.